BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32886924)

  • 1. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Kim GH; Min YW; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    PLoS One; 2020; 15(9):e0238113. PubMed ID: 32886924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
    Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma.
    Azuma Y; Dohi O; Naito Y; Yasuda T; Yoshida T; Ishida T; Kitae H; Matsumura S; Doi T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Takagi T; Ishikawa T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
    Esophagus; 2022 Apr; 19(2):278-286. PubMed ID: 34773554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan.
    Hsu MH; Wang WL; Chen TH; Tai CM; Wang HP; Lee CT
    BMC Gastroenterol; 2021 Aug; 21(1):308. PubMed ID: 34344303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic submucosal dissection under general anesthesia for superficial esophageal squamous cell carcinoma is associated with better clinical outcomes.
    Song BG; Min YW; Cha RR; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    BMC Gastroenterol; 2018 Jun; 18(1):80. PubMed ID: 29879909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive risk evaluation for metachronous carcinogenesis after endoscopic submucosal dissection of superficial pharyngeal squamous cell carcinoma.
    Ogasawara N; Kikuchi D; Tanaka M; Ochiai Y; Okamura T; Hayasaka J; Suzuki Y; Mitsunaga Y; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S
    Esophagus; 2022 Jul; 19(3):460-468. PubMed ID: 35099639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachronous carcinogenesis of superficial esophagus squamous cell carcinoma after endoscopic submucosal dissection: incidence and risk stratification during long-term observation.
    Ogasawara N; Kikuchi D; Inoshita N; Nakayama A; Kohno K; Ochiai Y; Hayasaka J; Suzuki Y; Dan N; Okamura T; Mitsunaga Y; Tanaka M; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S; Iizuka T
    Esophagus; 2021 Oct; 18(4):806-816. PubMed ID: 33974189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
    Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
    J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic submucosal dissection versus surgery for T1b esophageal carcinoma: a single-center retrospective study.
    Zhang T; Wang H; Jin T; Wu Z; Li X; Zhang Q
    J Cancer Res Clin Oncol; 2024 May; 150(5):248. PubMed ID: 38724804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
    Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
    Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after endoscopic resection for superficial esophageal squamous cell carcinoma: a multicenter Western study.
    Berger A; Rahmi G; Perrod G; Pioche M; Canard JM; Cesbron-Métivier E; Boursier J; Samaha E; Vienne A; Lépilliez V; Cellier C
    Endoscopy; 2019 Apr; 51(4):298-306. PubMed ID: 30261535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of endoscopic submucosal dissection in patients who develop metachronous superficial esophageal squamous cell carcinoma close to a post-endoscopic submucosal dissection scar.
    Fukuhara M; Urabe Y; Oka S; Mizuno J; Tanaka H; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Arihiro K; Tanaka S
    Esophagus; 2023 Jan; 20(1):124-133. PubMed ID: 35917040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
    Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal selection of endoscopic resection in patients with esophageal squamous cell carcinoma: endoscopic mucosal resection versus endoscopic submucosal dissection according to lesion size.
    Kawashima K; Abe S; Koga M; Nonaka S; Suzuki H; Yoshinaga S; Oda I; Hikichi T; Ohira H; Saito Y
    Dis Esophagus; 2021 May; 34(5):. PubMed ID: 32959874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of endoscopic submucosal dissection in elderly patients with esophageal squamous cell carcinoma.
    Song BG; Min YW; Lee JH; Lee H; Min BH; Rhee PL; Kim JJ
    Surg Endosc; 2017 Oct; 31(10):3905-3911. PubMed ID: 28342128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched analysis.
    Min YW; Lee H; Song BG; Min BH; Kim HK; Choi YS; Lee JH; Hwang NY; Carriere KC; Rhee PL; Kim JJ; Zo JI; Shim YM
    Gastrointest Endosc; 2018 Oct; 88(4):624-633. PubMed ID: 29750981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.
    Suzuki Y; Kikuchi D; Hoteya S; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Iizuka T
    Digestion; 2021; 102(4):622-629. PubMed ID: 32992320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic Submucosal Dissection Versus Surgery for Superficial Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Survival Analysis.
    Lee HD; Chung H; Kwak Y; Choi J; Lee A; Kim JL; Cho SJ; Kim SG
    Clin Transl Gastroenterol; 2020 Jul; 11(7):e00193. PubMed ID: 32675704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.